/ATMS
ATMS Stock - Artemis Therapeutics Inc.
Financial Services|Shell CompaniesOTC
$0.50-73.65%
$1.39 (-73.65%) • May 25
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.27
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ATMS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.49 – $0.50
TARGET (TP)$0.57
STOP LOSS$0.46
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$4.50
52W Low$0.11
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $311,000 | N/A | N/A | N/A | $259,000 |
| Gross Profit | $257,000 | N/A | N/A | N/A | $259,000 |
| Gross Margin | 82.6% | N/A | N/A | N/A | 100.0% |
| Operating Income | $-1,359,000 | $-154,000 | $-167,000 | $-168,000 | $-772,000 |
| Net Income | $-1,351,000 | $-180,000 | $-121,000 | $-121,000 | $513,000 |
| Net Margin | -434.4% | N/A | N/A | N/A | 198.1% |
| EPS | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.10 |
Company Overview
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ATMSBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2023
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 16, 2024 | — | — | — | — |
Q1 2024 | Mar 29, 2024 | — | — | — | — |
Q4 2023 | Nov 13, 2023 | — | — | — | — |
Q3 2023 | Aug 21, 2023 | — | — | — | — |
Q2 2023 | May 18, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.09 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 22, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 3, 2022 | — | $0.07 | — | — |
Q4 2021 | Nov 10, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ATMS
What is ATMS's current stock price?
Artemis Therapeutics Inc. (ATMS) is currently trading at $0.50 per share. The stock has moved -73.65% today.
What is the analyst price target for ATMS?
No analyst price targets are currently available for this stock.
What sector is Artemis Therapeutics Inc. in?
Artemis Therapeutics Inc. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.
What is ATMS's market cap?
Artemis Therapeutics Inc. has a market capitalization of $0.06 billion, making it a small-cap company.
Does ATMS pay dividends?
No, Artemis Therapeutics Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAOAO
Alpha One Inc.
$3.55
Mkt Cap: $0.0B
BHAC
Focus Impact BH3 Acquisition Co
$10.55
Mkt Cap: $0.1B
CLOE
Clover Leaf Capital Corp.
$12.47
Mkt Cap: $0.1B
IRAA
Iris Acquisition Corp
$6.43
Mkt Cap: $0.0B
JMTM
James Maritime Holdings, Inc.
$5.30
Mkt Cap: $0.0B
KWAC
Kingswood Acquisition Corp.
$13.30
Mkt Cap: $0.0B
PORT
Southport Acquisition Corporation
$11.99
Mkt Cap: $0.1B
PTCP
Petrocorp Inc.
$2.50
Mkt Cap: $0.1B
SLBK
Skyline Bankshares, Inc.
$18.50
Mkt Cap: $0.1B
Explore stocks similar to ATMS for comparison